NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/07/2025
Voltar para busca
Dado oficial do USPTO
PELVIVA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
25/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
17/06/2011
Data de registro
17/07/2012
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/02/2019
Última transação
25/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Cleveland, GB
Examinador
TWOHIG,SHANNON MARIE
Unidade examinadora
N20
Localização atual
TMO LAW OFFICE 120
Titulares e representantes
Titulares
Femeda Limited
Representantes
Mark Lerner Satterlee Stephens Burke & Burke LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of incontinence and urinary tract infections; feminine hygiene productspads for the treatment of incontinence; sanitary pads; panty linerssanitary napkinstamponssanitary briefsinterlabial feminine hygiene pads; sanitary preparations for medical purposes; medicated toiletries; incontinence pads and diapers; incontinence linersincontinence napkinsincontinence pants; cleaning preparations for feminine hygienemedicated feminine hygiene wash; pre-moistened medicated wipes for external vaginal and perineal cleansing; pads for feminine protection
Classe 10
Surgical and medical apparatus and instruments for the treatment of feminine incontinence; medical appliances for use by persons suffering from incontinence; electronic apparatus for the prevention of incontinenceelectronic stimulator for nerves of the pelvic floor; female urinary incontinence devicesincontinence sheets; pelvic floor exercisers for strengthening muscles of the pelvic floor; medical apparatus for testing muscles of the pelvic floor; pelvic muscle exercisers for medical purposesto strengthen weak pelvic floor muscles for the treatment of urge incontinencestress incontinence and mixed incontinence in women; vaginal exerciser to stimulate the pelvic muscles for medical purposesto strengthen weak pelvic floor muscles for the treatment of urge incontinencestress incontinence and mixed incontinence in women; apparatus and instrumentsall for use in the control of incontinence in human beingscathetersurethral insertspessaries; pelvic floor exercise weight kits containing cones for use in the control of incontinence in human beings; urine drainage bags for medical purposes; catheters; massage apparatusbody massagers; parts and fittings for all the aforesaid goods
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/01/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/02/2021
GPNX
NOTIFICATION PROCESSED BY IB
31/07/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/03/2020
RFNT
REFUSAL PROCESSED BY IB
10/01/2020
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
20/12/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
18/11/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
18/11/2019
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
22/10/2019
C71T
CANCELLED SECTION 71
22/02/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/11/2017
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
17/07/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/11/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/07/2013
NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/04/2013
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/03/2013
GPNX
NOTIFICATION PROCESSED BY IB
02/12/2012
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/11/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
17/10/2012
FIMP
FINAL DISPOSITION PROCESSED
17/10/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/10/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
17/07/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/05/2012
PUBO
PUBLISHED FOR OPPOSITION
01/05/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/04/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/04/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/04/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
23/03/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/03/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/03/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/03/2012
ALIE
ASSIGNED TO LIE
01/03/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/02/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/02/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/02/2012
RFNT
REFUSAL PROCESSED BY IB
24/12/2011
MAFR
APPLICATION FILING RECEIPT MAILED
08/12/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/12/2011
RFRR
REFUSAL PROCESSED BY MPU
07/12/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/12/2011
CNRT
NON-FINAL ACTION WRITTEN
06/12/2011
DOCK
ASSIGNED TO EXAMINER
04/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/12/2011
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PELVIVA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.